Cargando…

CRH-R splicing in estrogen-sensitive breast cancer

Detalles Bibliográficos
Autor principal:	Grammatopoulos, Dimitris K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2014
Materias:	Editorials: Cell Cycle Features
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979899/ https://www.ncbi.nlm.nih.gov/pubmed/24526122 http://dx.doi.org/10.4161/cc.27858

Ejemplares similares

A new path to oncogene-induced senescence: At the crossroads of splicing and translation
por: Das, Shipra, et al.
Publicado: (2013)

RNF8 - The Achilles heel of DNA repair when splicing rules
por: Pederiva, Chiara, et al.
Publicado: (2018)

Vaccines and early breast cancer
por: Caballero, Otavia L, et al.
Publicado: (2014)

miR-34a/SIRT6 in squamous differentiation and cancer
por: Dotto, G Paolo, et al.
Publicado: (2014)

The SRF-YAP-IL6 axis promotes breast cancer stemness
por: Kim, Tackhoon, et al.
Publicado: (2016)

miR-22 in tumorigenesis
por: Song, Su Jung, et al.
Publicado: (2014)

Revealing targeted therapeutic opportunities in triple-negative breast cancers: A new strategy
por: Poage, Graham M, et al.
Publicado: (2013)

Normalization of tumor vasculature by R-Ras
por: Sawada, Junko, et al.
Publicado: (2012)

The metabolic facet of pancreatic cancer: How hypoxia shapes fatal cancer cells
por: Guillaumond, Fabienne, et al.
Publicado: (2013)

“Sister” miRNAs in cancers
por: Wahdan-Alaswad, Reema, et al.
Publicado: (2013)

Targeting LIM kinase in cancer and neurofibromatosis
por: Rak, Roni, et al.
Publicado: (2014)

MET in ovarian cancer: Metastasis and resistance?
por: Tang, Chad, et al.
Publicado: (2014)

Targeting genetic lesions in esophageal cancer
por: Lin, De-Chen, et al.
Publicado: (2014)

The bright side of ascites in ovarian cancer
por: Cohen, Marie, et al.
Publicado: (2014)

Oxidizing to death: Disulfiram for cancer cell killing
por: Brüning, Ansgar, et al.
Publicado: (2014)

Cancer germline gene activation: Friend or foe?
por: McFarlane, Ramsay J, et al.
Publicado: (2014)

BETting on a new prostate cancer treatment
por: Asangani, Irfan A, et al.
Publicado: (2014)

MAPK signaling control of colon cancer metastasis
por: Urosevic, Jelena, et al.
Publicado: (2014)

TLS/FUS: A protein in cancer and ALS
por: Tan, Adelene Y., et al.
Publicado: (2012)

Restoring PML tumor suppression to combat cancer
por: Wolyniec, Kamil, et al.
Publicado: (2012)

Mitochondrial metabolism in TCA cycle mutant cancer cells
por: Sullivan, Lucas B, et al.
Publicado: (2014)

p53 and cancer stem cells: The mevalonate connexion
por: Ginestier, Christophe, et al.
Publicado: (2012)

To target or not to target the enemy within localized prostate cancer
por: Risbridger, Gail, et al.
Publicado: (2013)

New roles of Rb1 in expansion of MDSCs in cancer
por: Youn, Je-In, et al.
Publicado: (2013)

Does Smad6 methylation control BMP signaling in cancer?
por: Xu, Jian, et al.
Publicado: (2014)

Targeting the Achilles’ heel of drug-resistant cancer stem cells
por: Seguin, Laetitia, et al.
Publicado: (2014)

IF1 reprograms energy metabolism and signals the oncogenic phenotype in cancer
por: Sánchez-Aragó, María, et al.
Publicado: (2012)

“Take it up a NOTCH: ” Novel strategies for cancer therapy
por: Morgan, Stefanie L., et al.
Publicado: (2013)

Forever young? Exploring the link between rapamycin, longevity and cancer
por: Van Meter, Michael, et al.
Publicado: (2012)

NFκB drives TERT promoter reactivation in cancer
por: Tergaonkar, Vinay
Publicado: (2015)

Cancer-associated chromosomal deletions: Size makes a difference
por: Cai, Yanyan, et al.
Publicado: (2016)

Skp2: A dream target in the coming age of cancer therapy
por: Chan, Chia-Hsin, et al.
Publicado: (2014)

MicroRNA-regulated stress response in cancer and its clinical implications
por: Li, Haoran, et al.
Publicado: (2013)

Socs3 induction by PPARγ restrains cancer-promoting inflammation
por: Végran, Frédérique, et al.
Publicado: (2013)

Cancer hallmarks sustained by ectopic activations of placenta/male germline genes
por: Rousseaux, Sophie, et al.
Publicado: (2013)

Too much or too little: Harnessing senescence to control oncogene-driven cancer
por: Hannan, Katherine M., et al.
Publicado: (2012)

Pancreatic cancers rely on a novel glutamine metabolism pathway to maintain redox balance
por: Lyssiotis, Costas A., et al.
Publicado: (2013)

Targeting cancer cells resistant to hypoxia and nutrient starvation to improve anti-angiogeneic therapy
por: Osawa, Tsuyoshi, et al.
Publicado: (2013)

The FAT epidemic: A gene family frequently mutated across multiple human cancer types
por: Morris, Luc G.T., et al.
Publicado: (2013)

Induction of TRIF- or MYD88-dependent pathways perturbs cell cycle regulation in pancreatic cancer
por: Zambirinis, Constantinos P., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_i1ega2hlfg4ql3prlimtci1dsn